Illumina (ILMN)
(Real Time Quote from BATS)
$124.22 USD
+3.12 (2.58%)
Updated Aug 8, 2024 11:40 AM ET
1-Strong Buy of 5 1
D Value C Growth B Momentum C VGM
Brokerage Reports
Illumina, Inc. [ILMN]
Reports for Purchase
Showing records 281 - 300 ( 364 total )
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Checks Suggest ILMN Has Won an Exclusive Competitive Contract with Progenity
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Checks Suggest ILMN Has Won an Exclusive Competitive Contract with Progenity
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Strong 1Q14 Results & Guidance - New Product Stories Shaping Up Nicely - Raising Estimates & PT to $155 from $140 - Valuation Still Uncomfortable
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
1Q14 Preview - Checks Suggest Solid Consumable Trends - Tweaking Revenue Slightly Higher and EPS Lower for New Product Complexities - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Solid 4Q13 Call - Warming Up Following New Xten Order & FCF Improvement - Tweaking Estimates & Upping PT
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
4Q13 Preview: Expecting a Solid Call in Line with Preannouncement - Raising Estimates and PT to $130, Accounting for Impressive Dx Inflection
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Impressive Investor Day - Multiple New Products - NeoPrep Automated Sample Pre Device Stands Out - Diagnostics Theme Accelerating
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
3Q13 Beat & Raise Driven By Impressive System Sales Again - Bona Fide Applied Market Inflection Encouraging - Upping Estimates - Raising PT to $72
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Technical Analysis - Biotech Stocks Ignored and Oversold, Offering Good Entry
Provider: Drexel Hamilton, LLC
Analyst: SINE B
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Diagnostics Update: FMI IPO Perspective - Harmless Roche & PACB Partnership - iGenomics Remains the Anomaly in Pre-Natal - Reaffirm N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Updating Pre-Natal Cheatsheet Post Wedbush LS Conference - Average Risk Market Less Penetrated & Chinese Market Appears Stronger - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Solid 2Q13 Beat & Raise Driven By Strong HiSeq Systems & Upgrades - Applied Markets Solid - Warming To Leverage Story & ALL Tuck-In - PT to $60
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
2Q13 Preview - Expecting Solid Top Line and So-So EPS
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z